Merck

Biosim war heats up as Merck's Remicade & Enbrel biosimilars bag major wins in RA
BioPharma Dive
Wed, 06/10/15 - 11:10 am
Merck
Remicade
Enbrel
biosimilars
rheumatoid arthritis
Merck's best hep C strategy is niche marketing, game theory expert figures
Fierce Pharma Marketing
Wed, 06/10/15 - 09:49 am
Merck
game theory
hepatitis C
Drug switch study bolsters case for copies of biotech medicine
Yahoo/Reuters
Wed, 06/10/15 - 09:10 am
biosimilars
Merck
JNJ
Remicade
Giant Study Boosts Januvia, Merck's $6 Billion Drug
Forbes
Mon, 06/8/15 - 10:16 pm
Merck
Januvia
diabetes
Merck is Accused of Stonewalling Over Effectiveness of Mumps Vaccine
WSJ Pharmalot
Mon, 06/8/15 - 09:59 pm
Merck
vaccines
mumps
whistleblower lawsuits
Autoimmune Drugs to Drive Big Pharma Higher in Coming Years
24/7 Wall St
Mon, 06/8/15 - 09:58 pm
autoimmune disease
AbbVie
JNJ
Eli Lilly
Merck
Bristol-Myers Squibb
Pfizer
Merck, New England Patriots Boss Bet $30M on Antibiotics Startup, Spero
Forbes
Mon, 06/8/15 - 10:01 am
Merck
Spero
antibiotics
Merck's Quest To Revive The Market For Insomnia Drugs
Forbes
Thu, 06/4/15 - 08:20 pm
Merck
insomnia
Belsomra
Merck's 'landmark' Zetia data hits NEJM, giving a boost to all LDL-fighting meds
Fierce Biotech
Thu, 06/4/15 - 09:18 am
Merck
Zetia
New England Journal of Medicine
Vytorin
Jury sides with Merck and its execs in gender-bias case
Fierce Pharma
Wed, 06/3/15 - 12:33 pm
Merck
gender discrimination
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
Forbes
Wed, 06/3/15 - 11:04 am
ASCO
cancer immunotherapy
glioblastoma multiforme
Merck
Genentech
Celldex Therapeutics
The Biggest Selling Cancer Drugs In 2020 Show Significant Change Expected In Five Short Years
Forbes
Mon, 06/1/15 - 11:34 pm
ASCO
PDL-1 inhibitors
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
ASCO
Oncothyreon
Immunogen
Bristol-Myers Squibb
Merck
Clovis Oncology
Roche
CTI BioPharma
Celldex Therapeutics
Puma Biotechnology
Express Scripts
ASCO 15: The top 10 setbacks, advances and head scratchers
Fierce Biotech
Mon, 06/1/15 - 12:15 pm
ASCO
Celldex Therapeutics
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Clovis Oncology
AstraZeneca
Genentech
Your ASCO15 guide: A mixed bag for Bristol-Myers, big wins for Merck, J&J
BioPharma Dive
Sun, 05/31/15 - 11:21 am
ASCO
Bristol-Myers Squibb
JNJ
Merck
Keytruda
Opdivo
daratumumab
Merck Takes Aim at Gilead. Should You Worry?
Investopedia
Sat, 05/30/15 - 12:27 pm
Merck
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
grazoprevir/elbasvir
Can Cancer Killers Lift Bristol-Myers, Merck?
Barron's
Fri, 05/29/15 - 12:17 pm
Bristol-Myers Squibb
Merck
Keytruda
Opdivo
Merck submits NDA for new 2-in-1 hepatitis C treatment
BioPharma Dive
Fri, 05/29/15 - 10:44 am
Merck
hepatitis C
grazoprevir/elbagavir
grazoprevir
elbagavir
ASCO preview: What's coming for lung cancer
Medical Marketing and Media
Tue, 05/26/15 - 04:16 pm
ASCO
lung cancer
Bristol-Myers Squibb
Merck
Roche
Keytruda
Opdivo
Merck's Keytruda, BMS' Opdivo score European nods to keep immuno-oncology race blazing
Fierce Pharma
Fri, 05/22/15 - 12:04 pm
Merck
Keytruda
Bristol-Myers Squibb
Europe
PD-1 inhibitors

Pages